Crow Verdict: At first look, Blue Jet Healthcare looked like a troubled business with a focus on saccharin salts (artificial sweeteners). But it's only a quarter of its business, as it focuses more on contrast media intermediates (CMI), critical ingredients (a la API) in diagnostics. If you're like me, you should be in love with healthcare, API, and diagnostics stocks, especially in India where 65% adults do not exercise and are bound to get NCDs. We're looking at an age where healthcare stocks will zoom. And no doubt, a niche player like Blue Jet will manage to dip its beak in the flowing gold too. It's "the" leader in the CMI segment in India and is the largest exporter, though the latter irritates me a little because EU (it's largest market) can be unreliable. Still, the stable business gives me hope against the pure OFS, falling GMP, jittery market, and full valuations. I see at least a 15% pop. Apply but faint-hearted investors who worry about market's volatility can stay away from all IPOs till January.
Crow's skin in the game: 3 retail applications.
Crow's last APPLY recommendation: Plaza Wires (41% listing pop and currently up 118% at upper circuit).
Note: I couldn't read Capital Market's 37-rating review to understand its rationale. If you can, do take a look.
Always in restraint of Mrs. Crow.